Search research articles
Contact Us
Filters
Showing results (241-250 of 253) with videos related to
Page
of 26
Sort By:
Scientific Reports
|
February 26, 2021
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
Kevin A Lidberg, Andrew J Annalora, Marija Jozic, et al.
Scientific Reports
|
May 18, 2021
Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
Kevin A Lidberg, Andrew J Annalora, Marija Jozic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 7, 2015
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients
Jennifer S Ko, Victor G Prieto, Paul J Elson, et al.
JAMA Neurology
|
March 28, 2018
Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score
Andong Zhan, Srihari Mohan, Christopher Tarolli, et al.
Biochemical Pharmacology
|
July 28, 2023
Suppression of Ah Receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growth
Daniel J Elson, Bach D Nguyen, Nicholas A Korjeff, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
January 4, 2018
Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists
Molly J Elson, E Anna Stevenson, Blake A Feldman, et al.
Anticancer Research
|
April 12, 2003
Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study
Aleck A Hercbergs, Lav K Goyal, John H Suh, et al.
ACS Pharmacology & Translational Science
|
July 20, 2023
Induction of Aryl Hydrocarbon Receptor-Mediated Cancer Cell-Selective Apoptosis in Triple-Negative Breast Cancer Cells by a High-Affinity Benzimidazoisoquinoline
Daniel J Elson, Bach D Nguyen, Sebastian Bernales, et al.
Journal of Glaucoma
|
June 26, 2021
Early Experience With Full-scope Shared-care Teleglaucoma in Canada
Molly J Elson, Annette Giangiacomo, A Y Maa, et al.
Molecular Cancer Therapeutics
|
June 16, 2005
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors
David E Weng, Paul A Masci, Susan F Radka, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 253) with videos related to
Sort By:
Page
of 26
Scientific Reports
|
February 26, 2021
Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
Kevin A Lidberg, Andrew J Annalora, Marija Jozic, et al.
Scientific Reports
|
May 18, 2021
Author Correction: Antisense oligonucleotide development for the selective modulation of CYP3A5 in renal disease
Kevin A Lidberg, Andrew J Annalora, Marija Jozic, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 7, 2015
Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients
Jennifer S Ko, Victor G Prieto, Paul J Elson, et al.
JAMA Neurology
|
March 28, 2018
Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score
Andong Zhan, Srihari Mohan, Christopher Tarolli, et al.
Biochemical Pharmacology
|
July 28, 2023
Suppression of Ah Receptor (AhR) increases the aggressiveness of TNBC cells and 11-Cl-BBQ-activated AhR inhibits their growth
Daniel J Elson, Bach D Nguyen, Nicholas A Korjeff, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association
|
January 4, 2018
Telemedicine for Parkinson's Disease: Limited Engagement Between Local Clinicians and Remote Specialists
Molly J Elson, E Anna Stevenson, Blake A Feldman, et al.
Anticancer Research
|
April 12, 2003
Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study
Aleck A Hercbergs, Lav K Goyal, John H Suh, et al.
ACS Pharmacology & Translational Science
|
July 20, 2023
Induction of Aryl Hydrocarbon Receptor-Mediated Cancer Cell-Selective Apoptosis in Triple-Negative Breast Cancer Cells by a High-Affinity Benzimidazoisoquinoline
Daniel J Elson, Bach D Nguyen, Sebastian Bernales, et al.
Journal of Glaucoma
|
June 26, 2021
Early Experience With Full-scope Shared-care Teleglaucoma in Canada
Molly J Elson, Annette Giangiacomo, A Y Maa, et al.
Molecular Cancer Therapeutics
|
June 16, 2005
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors
David E Weng, Paul A Masci, Susan F Radka, et al.
Page
of 26